How common FIRE is and what it looks like in children with eosinophilic esophagitis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will enroll children aged 6–17 who are followed for eosinophilic esophagitis at the allergology unit of Angers University Hospital, with participation from CHU Lille, and collect standardized clinical histories focused on immediate esophageal reactions after eating. Because formal diagnostic criteria for FIRE are not established, investigators will use targeted questionnaires and chart review to distinguish FIRE from oropharyngeal allergy syndromes and from mechanical obstruction related to esophagitis. The study is observational and aims to establish prevalence, describe typical symptoms, and identify associated clinical features in the pediatric population. No experimental treatments or interventions are administered.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients over 6 and under 18 years of age at the time of inclusion
* Follow-up in the allergology unit of Angers University Hospital for eosinophilic esophagitis

Exclusion Criteria:

* Patients or legal representative with severe communication or language comprehension difficulties
* Patients or legal representatives objecting to study participation

Where it's running

• HOPPE Anne
  Angers, France Recruiting
• CHU Lille
  Lille, France Not yet recruiting

Study contacts

• Principal investigator: Anne HOPPE — University Hospital of Angers
• Study coordinator: Anne HOPPE, MD
• Email: anne.hoppe@chu-angers.fr
• Phone: 241353637

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Upadacitinib for Eosinophilic Esophagitis in adults not responding to standard therapy

  This study tests whether upadacitinib, taken with topical corticosteroids, can reduce disease activity in adults with eosinophilic esophagitis who still have symptoms.

  Recruiting Phase 2 University of North Carolina, Chapel Hill · Chapel Hill, North Carolina and 1 other locations · NCT07588568

• A registry for adults with esophageal movement and reflux problems.

  This project will collect esophageal function tests (manometry, pH-impedance, FLIP) and clinical data from adults with reflux or swallowing symptoms to see if combining these results helps guide diagnosis and long-term care.

  Recruiting IRCCS San Raffaele · Milan, Lombardy · NCT07506746

• Using a mucosal impedance device to help diagnose chronic esophageal problems

  This test tries a mucosal impedance device during upper endoscopy to see if it helps diagnose people with chronic reflux (GERD) or eosinophilic esophagitis.

  Recruiting Medical College of Wisconsin · Milwaukee, Wisconsin · NCT07227506

• Esophageal string test to screen for eosinophilic esophagitis in adults of African descent with swallowing problems

  This study will test whether a 1-hour esophageal string test can detect eosinophilic esophagitis in adults born in Africa (or with African parents) who have trouble swallowing.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland and 2 other locations · NCT07027826

• Improving management of eosinophilic esophagitis in children and adolescents

  This study is trying to find better ways to manage eosinophilic esophagitis in kids and teens by using simple tests to avoid invasive procedures and improve their quality of life.

  Recruiting at 2 sites Oslo University Hospital · Bergen and 1 other locations · NCT06991881

• Comparing dupilumab and topical corticosteroids for treating eosinophilic esophagitis

  This study is testing whether a new weekly injection called dupilumab works better than a daily swallowed medication for treating eosinophilic esophagitis in young people aged 12 to 25.

  Recruiting Phase 2 University of Colorado, Denver · Aurora, Colorado · NCT06705387

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.